Simcere Pharmaceutical Group Limited (02096) published its monthly return for the period ended January 31, 2026, confirming that the total number of issued shares remained at 2,595,697,618 with no adjustment during the month.

The company reconfirmed compliance with a public float requirement of 15.45%. Details also indicate that 10,851,000 shares had been repurchased for cancellation but not yet cancelled as of January 31, 2026. Furthermore, no new issuances were recorded under the restricted share unit scheme, leaving 237,370,361 shares still available for issuance or transfer under the plan.